pentaformylgitoxin (gitoformate)

structure

Also Known As:

gitoformate; 3 beta,14 beta- dihydroxy-16 beta-formyloxy-5 beta-card-20(22)- enolide 3-tetraformyltridigitoxoside; AC 2770; formiloxin; (3 beta,5 beta,16 beta)-3-((O-2,6-dideoxy-3,4-di-O-formyl- beta-D-ribo-hexopyranosyl-(1-4)-O-2,6-dideoxy-3-O-formyl-beta-D-ribo-hexanopyranosyl-(1-4)-2,6-dide oxy-3-O-formyl-beta-D-ribo-hexanopyranosyl)oxy)- 16-(formyloxy)-14-hydroxycard-20(22)-enolide

Networked: 6 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Related Diseases

1.	Atrial Fibrillation 01/01/1981 - "[Pharmacokinetics and pharmacodynamics of gitoformate in subjects with atrial fibrillation]." 12/01/1983 - "[Circadian aspects of heart rate in patients with atrial fibrillation: comparative influence of digoxin and pentaformylgitoxin]." 12/01/1983 - "[Circadian aspects of the heart rate in atrial fibrillation patients: the comparative effect of digoxin and pentaformylgitoxin]."
2.	Renal Insufficiency (Renal Failure) 01/01/1981 - "[Pharmacokinetics of gitoformate in subjects with renal insufficiency under dialysis treatment]." 03/01/1979 - "[Effect of renal insufficiency on the pharmacokinetic parameters of gitoformate in man]."
3.	Chronic Renal Insufficiency 01/01/1979 - "[Gitoformate in chronic renal insufficiency: pharmacokinetic aspects]."

Related Drugs and Biologics

1.	Digoxin (Digitek)

HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Application Error

An application error has occurred and our support engineers have been notified.

Please use the browser "Back" button and try your operation again.

OR if the error persists and you require an email response
please contact us at "cs at curehunter.com":

Your request
The circumstances of the error
Your login id/nickname or email

Return to Top Page